BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7834464)

  • 1. Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Frankel J
    Cancer Invest; 1995; 13(1):1-7. PubMed ID: 7834464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
    Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
    Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Saltz L; Frankel J
    Cancer; 1993 Jun; 71(11):3486-92. PubMed ID: 8490898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):821-7. PubMed ID: 8478232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
    Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
    Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
    Ann Oncol; 1999 Jun; 10(6):671-6. PubMed ID: 10442189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass J; Conti J
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):289-95. PubMed ID: 9069299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
    Minsky B; Cohen A; Enker W; Kelsen D; Kemeny N; Ilson D; Guillem J; Saltz L; Frankel J; Conti J
    Cancer; 1994 Jan; 73(2):273-80. PubMed ID: 8293388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
    Minsky BD; Cohen AM; Enker WE; Kelsen DP; Kemeny N; Riechman B; Saltz L; Sigurdson ER; Frankel J
    Int J Radiat Oncol Biol Phys; 1992; 22(1):139-45. PubMed ID: 1727111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Aug; 10(8):1218-24. PubMed ID: 1634912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma.
    Grann A; Feng C; Wong D; Saltz L; Paty PP; Guillem JG; Cohen AM; Minsky BD
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):987-95. PubMed ID: 11240239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer. Results of a phase II study.
    Giralt J; Rubio D; Maldonado X; Naval J; Casado S; Lara F; Roselló JM; Armengol M
    Acta Oncol; 1997; 36(1):51-4. PubMed ID: 9090966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
    Minsky BD; Kemeny N; Cohen AM; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    Cancer; 1991 Jun; 67(11):2859-66. PubMed ID: 2025851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
    Carraro S; Roca EL; Cartelli C; Rafailovici L; Castillo Odena S; Wasserman E; Gualdrini U; Huertas E; Barugel M; Ballarino G; Rodriguez MC; Masciangioli G
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):397-402. PubMed ID: 12243813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.